DCF — VASSAR BROTHERS MEDICAL CENTER
Enterprise Value: $-400.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-400.5M
Enterprise Value
$-143.7M
PV of Cash Flows
$-256.7M
PV of Terminal Value
$-413.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $757.2M | $-15.7M | -2.0% | $-47.7M | $-43.4M |
| Year 2 | $779.9M | $-8.3M | -1.0% | $-41.3M | $-34.2M |
| Year 3 | $803.3M | $-0.5M | -0.0% | $-34.5M | $-26.0M |
| Year 4 | $827.4M | $3.6M | 0.0% | $-31.4M | $-21.5M |
| Year 5 | $852.2M | $5.8M | 1.0% | $-30.3M | $-18.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-400.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$735.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.025668483225121903
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5